Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan/amlodipine versus high-dose amlodipine in older adults with essential hypertension uncontrolled on amlodipine 5 mg
2006-004586-34Phase 3Completed
- Sponsor
- Novartis
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in essential hypertension comparing Valsartan + amlodipine with Amlodipine monotherapy (2 arms). Primary endpoint: Reduction in mean sitting systolic blood pressure from baseline to week 8. Started Nov 2006; status: completed.
02
Drugs
valsartanamlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2006-004586-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004586-34.